CVR: 40804307
Secondary names: Gebamo ApS, Twelve Bio ApS
Previous names: GEBAMO ApS, Twelve Bio ApS
Selskabets formål er at udvikle og kommercialisere medicinske lægemidler samt anden virksomhed, der står i forbindelse hermed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | -3.4 mio. | -5.4 mio. | 2.8 mio. | 2.1 mio. | 17 | |
Compared to 997 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Anders Anton Maier joined the board
Magnus Glissmann Bojer-Larsen joined as director
Stefano Stella left as director
Companies in the same industry and area
CVR 40766383
CVR 34688605
CVR 44504332
CVR 43917897
CVR 41997907
companydata.dk